Market News

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and raises the price target from $72 to $74.

Dividend to shareholders of record at the close of business on July 22, 2026 (the "Record Date"). The dividend will be paid on or about August...

SHIB burn hits a 6-month high, but Shiba Inu's price holds flat. The massive deflationary spike fails to spark a breakout for the token

Envela Corp. (ELA) meets all eight criteria of Louis Navellier's growth stock strategy, with 54% revenue growth, 189% EPS surge, strong profitability,...

Wells Fargo analyst Chris Carey maintains Spectrum Brands Holdings (NYSE:SPB) with a Equal-Weight and raises the price target from $80 to $85.

https://www.wsj.com/finance/banking/jpmorgan-plans-to-target-small-company-deals-as-part-of-m-a-push-793b74f4

VNET Group rides the AI infrastructure wave but faces extreme equity sensitivity due to high leverage and thin residual value. See why I rate VNET sto...

Smurfit Westrock is expected to report its fiscal 2026 second-quarter results soon, with analysts forecasting double-digit earnings growth.

Wells Fargo analyst Chris Carey maintains Kimberly-Clark (NASDAQ:KMB) with a Equal-Weight and raises the price target from $100 to $110.

Here's today's price of gold, plus three easy ways you can add the precious metal to your portfolio.

Tesla is working towards developing smarter voice commands for Full Self-Driving, targeting a familiar last-mile problem.

Cantor Fitzgerald analyst Li Watsek initiates coverage on Immuneering (NASDAQ:IMRX) with a Overweight rating.

Wells Fargo analyst Chris Carey maintains Edgewell Personal Care (NYSE:EPC) with a Overweight and raises the price target from $24 to $30.

OS Therapies, Inc. (NYSE:OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, Listeria-based cancer immunotherapi...

Super Micro Computer, Inc. (NASDAQ:SMCI), an AI, Enterprise, Storage, and 5G/Edge Total IT Solution Provider featuring Data Center Building Block Solu...

A novel theranostics study explores imaging- and data-informed approaches to support individualized treatment decisions and expand access to theranost...

Warren Buffett says traders as treating the stock market like a gambling parlor.

Cantor Fitzgerald analyst Steve Seedhouse assumes EyePoint (NASDAQ:EYPT) with a Overweight rating and announces Price Target of $47.

Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $92 to $95.

Market breadth cooled sharply as chip weakness hit QQQ, but moving-average participation and medium-term breadth still support a neutral-positive tren...